Veracyte

Veracyte is a genomic diagnostics company developing molecular tests and an AI-driven diagnostic platform across thyroid, lung, prostate, breast, and bladder cancers, plus interstitial lung disease. The company combines RNA sequencing assays with machine learning classifiers to help clinicians decide on biopsies, surgeries, and treatment intensification. Veracyte's tests including Afirma, Percepta, Decipher, and Envisia are widely covered by Medicare and major payers and integrated into NCCN guidelines for several conditions.